08:39 AM EST, 12/26/2024 (MT Newswires) -- Health care stocks declined premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and the iShares Biotechnology ETF (IBB) was about 1% lower recently.

TScan Therapeutics ( TCRX ) shares rose past 20% premarket after the company said it signed a securities purchase agreement with Lynx1 Capital Management and an investment fund advised by Lynx1 for the sale of about $30 million of pre-funded warrants.